Lachmann PJ - Search Results

1

Seligmann M, Chess L, Fahey JL, Fauci AS, Lachmann PJ, L'Age-Stehr J, Ngu J, Pinching AJ, Rosen FS, Spira TJ, et al. Seligmann M, et al. Among authors: lachmann pj. N Engl J Med. 1984 Nov 15;311(20):1286-92. doi: 10.1056/NEJM198411153112005. N Engl J Med. 1984. PMID: 6092954 Review. No abstract available.

2

The catabolism of C1(-)-inhibitor and the pathogenesis of hereditary angio-edema.

Lachmann PJ, Rosen FS. Lachmann PJ, et al. Acta Pathol Microbiol Immunol Scand Suppl. 1984;284:35-9. Acta Pathol Microbiol Immunol Scand Suppl. 1984. PMID: 6587741

3

The mechanism of action of the C3b inactivator (conglutinogen-activating factor) on its naturally occurring substrate, the major fragment of the third component of complement (C3b).

Gitlin JD, Rosen FS, Lachmann PJ. Gitlin JD, et al. Among authors: lachmann pj. J Exp Med. 1975 May 1;141(5):1221-6. doi: 10.1084/jem.141.5.1221. J Exp Med. 1975. PMID: 1168693 Free PMC article.

4

Inactivator of the third component of complement as an inhibitor in the properdin pathway.

Alper CA, Rosen FS, Lachmann PJ. Alper CA, et al. Among authors: lachmann pj. Proc Natl Acad Sci U S A. 1972 Oct;69(10):2910-3. doi: 10.1073/pnas.69.10.2910. Proc Natl Acad Sci U S A. 1972. PMID: 4507613 Free PMC article.

5

Simultaneous turnover of normal and dysfunctional C1 inhibitor as a probe of in vivo activation of C1 and contact activatable proteases.

Woo P, Lachmann PJ, Harrison RA, Amos N, Cooper C, Rosen FS. Woo P, et al. Among authors: lachmann pj. Clin Exp Immunol. 1985 Jul;61(1):1-8. Clin Exp Immunol. 1985. PMID: 4042415 Free PMC article.

6

Deficiency of C3 inactivator in man.

Abramson N, Alper CA, Lachmann PJ, Rosen FS, Jandl JH. Abramson N, et al. Among authors: lachmann pj. J Immunol. 1971 Jul;107(1):19-27. J Immunol. 1971. PMID: 4997111 No abstract available.

7

Dysfunctional C1-inhibitor(At), isolated from a type II hereditary-angio-oedema plasma, contains a P1 'reactive centre' (Arg444----His) mutation.

Aulak KS, Pemberton PA, Rosen FS, Carrell RW, Lachmann PJ, Harrison RA. Aulak KS, et al. Among authors: lachmann pj. Biochem J. 1988 Jul 15;253(2):615-8. doi: 10.1042/bj2530615. Biochem J. 1988. PMID: 3178731 Free PMC article.

8

Restoration by purified C3b inactivator of complement-mediated function in vivo in a patient with C3b inactivator deficiency.

Ziegler JB, Alper CA, Rosen RS, Lachmann PJ, Sherington L. Ziegler JB, et al. Among authors: lachmann pj. J Clin Invest. 1975 Mar;55(3):668-72. doi: 10.1172/JCI107975. J Clin Invest. 1975. PMID: 1117072 Free PMC article.

9

Breakdown of C3 after complement activation. Identification of a new fragment C3g, using monoclonal antibodies.

Lachmann PJ, Pangburn MK, Oldroyd RG. Lachmann PJ, et al. J Exp Med. 1982 Jul 1;156(1):205-16. doi: 10.1084/jem.156.1.205. J Exp Med. 1982. PMID: 6177820 Free PMC article.

10

The detection and characterization of a membrane protein with Factor B-like activity on human lymphoid cells.

Woo P, Lachmann PJ. Woo P, et al. Among authors: lachmann pj. Immunology. 1981 Nov;44(3):629-39. Immunology. 1981. PMID: 6976310 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

346 results

Search Page

Filters